Revive Therapeutics CSE: RVV | OTC: RVVTF Revive Therapeutics is focused on the R&D and sale of cannabinoid-based products, recently expanding into the psychedelics industry more broadly. Revive Therapeutics$0.3411.48%$0.035 Latest News Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation February 15, 2022 Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs January 17, 2022 Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of Psilocybin Microneedle Patch November 3, 2021 Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer August 17, 2021 Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline August 10, 2021 Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics June 17, 2021 Join our Newsletter Get the latest Company updates delivered to straight to your inbox. Leave this field empty if you're human: